Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors

Shi-Ming Chen1, Ze-Zhang Tao, Qing-Quan Hua

  • 1Department of Otolaryngology-Head & Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. shimingchen0468@hotmail.com

Cancer Investigation
|December 7, 2007
PubMed

Insights

Short hairpin RNA (shRNA) targeting human telomerase reverse transcriptase (hTERT) mRNA effectively reduced cancer cell viability and telomerase activity. This RNA interference strategy showed no adverse effects on healthy stem cells, indicating its potential for cancer treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Telomerase activity, regulated by the human telomerase reverse transcriptase (hTERT) gene, is crucial for cancer cell proliferation.
  • Targeting hTERT offers a potential strategy for cancer therapy by inhibiting telomerase function.

Purpose of the Study:

  • To investigate the efficacy of short hairpin RNA (shRNA) targeting hTERT mRNA in reducing telomerase activity and viability in laryngeal and nasopharyngeal cancer cells.
  • To assess the safety and specificity of this approach in healthy human bone marrow mesenchyme stem cells (hMSCs).

Main Methods:

  • Construction of shRNA expression vectors targeting hTERT mRNA.
  • Treatment of laryngeal cancer cells (Hep-2), nasopharyngeal carcinoma cells (NEC), and hMSCs with hTERT-specific shRNA or control vectors.
  • Evaluation of hTERT expression, telomerase activity, and cell viability post-treatment.

Main Results:

  • shRNA targeting hTERT significantly decreased hTERT expression, telomerase activity, and cell viability in Hep-2 and NEC cells.
  • Control vectors did not induce these effects.
  • hMSCs, which naturally have low telomerase activity, showed no significant changes in response to the shRNA treatment.

Conclusions:

  • shRNA-mediated suppression of hTERT effectively inhibits telomerase activity and cell viability in cancer cells.
  • This RNA interference approach demonstrates specificity, sparing healthy cells and suggesting potential as a targeted cancer therapy.
  • RNA interference targeting hTERT represents a promising strategy for cancer treatment with minimal side effects on healthy tissues.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...